Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xolair in Chronic Sinusitis
NCT00603785Phase 4Withdrawn
- Sponsor
- University of California, San Francisco
- Start
- Jan 2008
- Primary completion
- Apr 2008
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of omalizumab in sinusitis, sponsored by University of California, San Francisco. Planned start Jan 2008; status: withdrawn.
02
Drugs
omalizumab
03
Conditions
sinusitis
Beyond the preview
Go deeper on NCT00603785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00603785.